OnKure Therapeutics, Inc. (OKUR) vs Rallybio Corporation (RLYB)
- OnKure Therapeutics, Inc. OKUR 2.41 +4.78%
- Rallybio Corporation RLYB 17.02 +0.18%
OnKure Therapeutics, Inc. and Rallybio Corporation are both Biotechnology companies. OnKure Therapeutics, Inc. and Rallybio Corporation are of similar size ($93.2M and $90.2M). OnKure Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.1×. Across the 10 metrics below, Rallybio Corporation leads on 7 and OnKure Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | OKUR | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (46.91%) | 64.86% | (56.66%) |
| Return on assets | (44.24%) | 61.12% | (49.22%) |
| Return on invested capital | 0.00% | (1,052.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack